February 28, 2026
A Stronger Future for SCARD
SCARD is pleased to announce the appointment of Dr Vin Rajeswaran as Chief Medical Officer. Dr Rajeswaran joins the platform with extensive experience in clinical governance, medical education, and digital health innovation. His leadership will support SCARD’s continued growth and ensure the platform remains at the forefront of structured skin cancer audit and data reporting. […]
What Is Continued Access Mode?
As SCARD transitions to a subscription-based model, we want to clearly explain how Continued Access Mode operates and what it means for users. If your 30-day trial ends or your subscription is not renewed, your account moves to Continued Access Mode. […]
Fee Structure and Access Update
Dear SCARD Users, Following our November communication and the valuable feedback we received from the SCARD community, we are writing to confirm the fee structure and access arrangements for the SCARD Audit. Your support reinforced the importance of SCARD as a clinical audit tool, and this next step ensures the platform remains secure, sustainable, and able to continue supporting best practice in skin cancer care. […]
December 28, 2025
The SCARD Surgical Audit CPD Program: 2026 – 2028 Triennium
The SCARD Surgical Audit CPD Program: 2026 – 2028 Triennium The commencement of the 2026–2028 CPD triennium marks an important milestone for practitioners participating in the SCARD Surgical Audit CPD Program. As professional development requirements continue to evolve, SCARD remains committed to providing a structured, evidence-based audit framework that supports high-quality clinical practice, reflective learning, and measurable improvement in skin cancer management within primary care. […]
February 22, 2025
From Data to Insight: How Real-World Audit Supports Diagnostic Accuracy in Primary Care
In primary care skin cancer practice, meaningful improvement is driven by understanding patterns in everyday clinical work. Real-world audit allows practitioners to move beyond individual cases and identify trends across their own practice over time. By collecting structured clinical data at the point of care, audit transforms routine activity into insight that can inform decision-making, reflection, and ongoing learning. […]
October 20, 2024
Supporting Rural and Remote Practitioners Through Flexible Audits
Delivering high-quality skin cancer care in rural and remote settings comes with unique challenges. Lower patient volumes, broader scopes of practice, workforce limitations, and geographic isolation can make participation in structured quality improvement activities more difficult than in metropolitan environments. Despite these challenges, ongoing audit, reflection, and continuous improvement remain essential to safe and effective patient care. […]
January 6, 2024
Discovering Insights: 2023 in Review at SCARD
As we reflect on the year 2023 at SCARD, we are thrilled to share with our community the comprehensive review of our journey and milestones achieved. Our sister site, skin.org.au, has just published an insightful article, “2023: A Year in Review for SCARD,” capturing the essence of our progress and the significant advancements made in skin cancer research and practice. […]
September 5, 2023
Lights in a dark room: visualizing data from SCARD
In the realm of medical practice and research, the significance of data analysis cannot be overstated. Medical professionals constantly grapple with a wealth of patient information, but the manner in which they digest and utilize this data can have a profound impact on decision-making and patient outcomes. One critical consideration in this process is the choice between raw statistics and visual data representation, such as graphs and charts. To assist all health care professionals, SCARD have just released our updated report platform for public data, including heat maps and reports from the SCARD Research Pool. […]
July 28, 2023
Calculating the results – Computing power
As you would no doubt expect, medical research requires significant compute power to process and analyse vast amounts of complex data. With the increasing prevalence of skin cancer cases and the need to improve diagnostic accuracy and treatment options, researchers heavily rely on advanced computational resources to make meaningful advancements in this field. The compute power required for skin cancer research plays a crucial role in handling high-resolution images, genetic sequencing data, and other large datasets obtained from patient samples and clinical studies. […]
June 9, 2023
The SCARD platform: security and compliance
Is it secure? With the regular reports of data breaches worldwide, security and compliance for SCARD is a daily focus for us. This post aims to provide you with some information on the technologies used by SCARD and how each component is independently secure and contributes to the overall compliance of SCARD. Since SCARD is also between versions (Version 4 > Version 5), we’re including details about both the legacy platform as well as the new system that is undergoing trials with users. […]
May 29, 2023
UQ GP Newsletter for May 2023
The recent publication “Practitioner characteristics, diagnostic accuracy metrics and discovering-individual with respect to 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database” was featured in the University of Queensland’s GP newsletter for May 2023 as the “Research article focus”. […]
April 24, 2023
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual
Knowledge of accuracy for melanoma diagnosis and melanoma discovering-individual in primary care is limited. We describe general practitioner (GP) characteristics and analyse defined diagnostic accuracy metrics for GPs in the current study comparing this with a previous study for GPs common to both, and we analyse the individual first discovering each melanoma as a lesion of concern. […]